Mark Krailo
Impact in
- Pulmonary and Respiratory Medicine top 0.1%
- Sarcoma Diagnosis and Treatment
- Neurology top 0.2%
- Neuroblastoma Research and Treatments
Papers in
-
- Sarcoma Diagnosis and Treatment 73
- Neurology 32
- Neuroblastoma Research and Treatments 29
- Co-authors
- Holcombe E. Grier (30 shared papers)Gregory H. Reaman (45 shared papers)Susan M. Blaney (37 shared papers)Malcolm C. Pike (9 shared papers)Mark L. Bernstein (29 shared papers)Paul A. Meyers (22 shared papers)Brian E. Henderson (5 shared papers)Peter C. Adamson (32 shared papers)
- Journals
- Journal of Clinical Oncology (70 papers)Pediatric Blood & Cancer (55 papers)Cancer (41 papers)Journal of Pediatric Surgery (13 papers)Clinical Cancer Research (12 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Mark Krailo
355 papers receiving 23.3k citations
Mark Krailo's Hit Papers
Peers
Comparison fields: 5 of 162
- Pulmonary and Respiratory Medicine 8.2k
- Neurology 3.2k
- Hepatology 1.6k
- Oncology 5.5k
- Genetics 1.6k
Countries citing papers authored by Mark Krailo
This map shows the geographic impact of Mark Krailo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Krailo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Krailo more than expected).
Fields of papers citing papers by Mark Krailo
This network shows the impact of papers produced by Mark Krailo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Krailo. The network helps show where Mark Krailo may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Krailo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 360 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone Hit paper breakdown → | 2003 | 1055 |
| 2 | Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate Hit paper breakdown → | 2005 | 613 |
| 3 | Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group Hit paper breakdown → | 2008 | 606 |
| 4 | ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer Hit paper breakdown → | 1983 | 571 |
| 5 | Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group Hit paper breakdown → | 2012 | 558 |
| 6 | Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort Hit paper breakdown → | 2019 | 490 |
| 7 | 1991 | 420 | |
| 8 | Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial Hit paper breakdown → | 2016 | 400 |
| 9 | 1997 | 395 | |
| 10 | Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial Hit paper breakdown → | 2015 | 347 |
| 11 | 2016 | 316 | |
| 12 | 1983 | 296 | |
| 13 | 2000 | 283 | |
| 14 | 1985 | 281 | |
| 15 | 2009 | 264 | |
| 16 | 2014 | 259 | |
| 17 | 2005 | 257 | |
| 18 | 1990 | 253 | |
| 19 | 1999 | 244 | |
| 20 | 2008 | 225 |
About Mark Krailo
Mark Krailo is a scholar working on Pulmonary and Respiratory Medicine, Neurology, Oncology, Surgery and Hepatology, having authored 360 papers that have together received 24.5k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (73 papers), Testicular diseases and treatments (49 papers), Neuroblastoma Research and Treatments (29 papers), Acute Lymphoblastic Leukemia research (28 papers), Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Glioma Diagnosis and Treatment (18 papers), Childhood Cancer Survivors' Quality of Life (17 papers) and Lymphoma Diagnosis and Treatment (16 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (8.2k citations), Neurology (3.2k citations), Hepatology (1.6k citations), Oncology (5.5k citations) and Genetics (1.6k citations). Mark Krailo has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Holcombe E. Grier, Gregory H. Reaman, Susan M. Blaney, Malcolm C. Pike, Mark L. Bernstein, Paul A. Meyers, Brian E. Henderson, Peter C. Adamson, Zhengjia Chen and Richard B. Womer. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, Cancer, Journal of Pediatric Surgery and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.